DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Lawitz E, Poordad F, Kowdley KV et al.
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C / C patients with chronic hepatitis C genotype 1.

Journal of hepatology 2013;
59: 18-23

Download Bibliographical Data

Search in:
Access: